NASDAQ:IRTC - Irhythm Technologies Stock Price, Forecast & News

Irhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Irhythm Technologies Inc (NASDAQ:IRTC) issued its quarterly earnings data on Tuesday, November, 5th. The company reported ($0.74) EPS for the quarter, missing analysts' consensus estimates of ($0.40) by $0.34. The firm earned $55.96 million during the quarter, compared to analyst estimates of $53.76 million. Irhythm Technologies had a negative net margin of 26.45% and a negative return on equity of 67.44%. The business's quarterly revenue was up 46.9% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.43) earnings per share. View Irhythm Technologies' Earnings History.

Irhythm Technologies is scheduled to release their next quarterly earnings announcement on Tuesday, February 11th 2020. View Earnings Estimates for Irhythm Technologies.

Irhythm Technologies issued an update on its FY 2019 Pre-Market earnings guidance on Monday, December, 23rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $213-214 million, compared to the consensus revenue estimate of $216.89 million.

11 brokerages have issued 1 year target prices for Irhythm Technologies' stock. Their forecasts range from $75.00 to $125.00. On average, they expect Irhythm Technologies' share price to reach $103.00 in the next twelve months. This suggests a possible upside of 15.4% from the stock's current price. View Analyst Price Targets for Irhythm Technologies.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Irhythm Technologies in the last year. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Irhythm Technologies.

Media headlines about IRTC stock have been trending very positive this week, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Irhythm Technologies earned a news sentiment score of 3.9 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days. View News Stories for Irhythm Technologies.

Some companies that are related to Irhythm Technologies include ABIOMED (ABMD), Hill-Rom (HRC), Penumbra (PEN), Haemonetics (HAE), Globus Medical (GMED), Integra Lifesciences (IART), Tandem Diabetes Care (TNDM), NuVasive (NUVA), ICU Medical (ICUI), Nevro (NVRO), Cantel Medical (CMD), Glaukos (GKOS), Merit Medical Systems (MMSI), Inspire Medical Systems (INSP) and Cardiovascular Systems (CSII).

Based on aggregate information from My MarketBeat watchlists, some companies that other Irhythm Technologies investors own include Alibaba Group (BABA), Twilio (TWLO), Tandem Diabetes Care (TNDM), DexCom (DXCM), NVIDIA (NVDA), Splunk (SPLK), Canopy Growth (CGC), Paycom Software (PAYC), Netflix (NFLX) and Paypal (PYPL).

(IRTC) raised $76 million in an initial public offering on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Irhythm Technologies' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Cerebellum GP LLC (0.01%) and Exchange Traded Concepts LLC (0.00%). Company insiders that own Irhythm Technologies stock include Bruce G Bodaken, David A Vort, Derrick Sung, Kevin M King, Matthew C Garrett, Merz Cathleen Noel Bairey, Raymond W Scott and Vijay K Lathi. View Institutional Ownership Trends for Irhythm Technologies.

IRTC stock was bought by a variety of institutional investors in the last quarter, including Exchange Traded Concepts LLC and Cerebellum GP LLC. View Insider Buying and Selling for Irhythm Technologies.

Shares of IRTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of IRTC stock can currently be purchased for approximately $89.27.

Irhythm Technologies has a market capitalization of $2.38 billion and generates $147.29 million in revenue each year. The company earns $-48,280,000.00 in net income (profit) each year or ($1.89) on an earnings per share basis. Irhythm Technologies employs 748 workers across the globe.View Additional Information About Irhythm Technologies.

The official website for Irhythm Technologies is http://www.irhythmtech.com/.

Irhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The company can be reached via phone at 415-632-5700 or via email at [email protected]